Cargando…
Repurposing a Drug Targeting Inflammatory Bowel Disease for Lowering Hypertension
BACKGROUND: The gut and gut microbiota, which were previously neglected in blood pressure regulation, are becoming increasingly recognized as factors contributing to hypertension. Diseases affecting the gut such as inflammatory bowel disease (IBD) present with aberrant energy metabolism of colonic e...
Autores principales: | Mei, Xue, Mell, Blair, Manandhar, Ishan, Aryal, Sachin, Tummala, Ramakumar, Kyoung, Jun, Yang, Tao, Joe, Bina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798790/ https://www.ncbi.nlm.nih.gov/pubmed/36533597 http://dx.doi.org/10.1161/JAHA.122.027893 |
Ejemplares similares
-
Identification of Upstream Transcriptional Regulators of Ischemic Cardiomyopathy Using Cardiac RNA-Seq Meta-Analysis
por: Alimadadi, Ahmad, et al.
Publicado: (2020) -
QTL mapping of rat blood pressure loci on RNO1 within a homologous region linked to human hypertension on HSA15
por: Mell, Blair, et al.
Publicado: (2019) -
Survey and Evaluation of Hypertension Machine Learning Research
por: du Toit, Clea, et al.
Publicado: (2023) -
Mutation within the hinge region of the transcription factor Nr2f2 attenuates salt-sensitive hypertension
por: Kumarasamy, Sivarajan, et al.
Publicado: (2015) -
Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis
por: Sherman, Shermel B., et al.
Publicado: (2018)